Affinity Asset Advisors, LLC
Q1 2022 13F Holdings
- Locationnew york, NY
- Num holdings
59
- Value ($000)
$625,043
- Date Filed05/13/2022
- Form type13F-HR
- CIK0001773195
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2022 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $338.73 M | 54 % | 750,000 | put | |
NARI INARI MED INC | COM | 45332Y109 | $19.94 M | 3 % | 220,000 | ||
MORF MORPHIC HLDG INC | COM | 61775R105 | $18.70 M | 3 % | 465,654 | ||
KURA KURA ONCOLOGY INC | COM | 50127T109 | $14.86 M | 2 % | 924,147 | ||
ASND ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | $14.08 M | 2 % | 120,000 | ||
SWTX SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | $13.94 M | 2 % | 247,000 | ||
KDNY CHINOOK THERAPEUTICS INC | COM | 16961L106 | $13.83 M | 2 % | 845,155 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | $11.76 M | 2 % | 174,500 | ||
TVTX 2.5 09/15/25 TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | $11.49 M | 2 % | 11,000,000 | ||
AZN ASTRAZENECA PLC | SPONSORED ADR | 046353108 | $10.61 M | 2 % | 160,000 |
Rows Per Page
10
- 10
- 50
- 100